| Stage | APO | % of rev | IR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $11.2B | 100.00% | $2.1B | 100.00% | APO ×5.40 |
| Gross profit | $10.2B | 91.69% | $924M | 44.76% | APO +46.9pp |
| Operating income | $2.4B | 21.63% | $783M | 37.90% | IR +16.3pp |
| Pre-tax income | $2.5B | 22.28% | $725M | 35.12% | IR +12.8pp |
| Net income | $2.1B | 18.73% | $672M | 32.52% | IR +13.8pp |
| Stage | APO | IR | Gap · A − B |
|---|---|---|---|
| Revenue | $11.2B100.00% | $2.1B100.00% | APO ×5.40 |
| Gross profit | 91.69%$10.2B | 44.76%$924M | APO +46.9pp |
| Operating income | 21.63%$2.4B | 37.90%$783M | IR +16.3pp |
| Pre-tax income | 22.28%$2.5B | 35.12%$725M | IR +12.8pp |
| Net income |
| 18.73%$2.1B |
| 32.52%$672M |
| IR +13.8pp |